Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trial

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By